Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	18.75	22.26	30.56	19.78	9.94	20.34
Short-Term Investments	15.18	44.55	57.04	64	0.96	15.45
Cash & Short-Term Investments	33.92	66.81	87.6	83.79	10.9	35.79
Cash Growth	-47.95%	-23.73%	4.55%	668.95%	-69.56%	-
Receivables	0.08	0.09	0.1	0.1	0.12	0.17
Inventory	0.19	0.17	0.15	0.28	0.07	0.07
Prepaid Expenses	1.69	2.09	1.27	0.53	0.23	0.23
Total Current Assets	35.88	69.17	89.11	84.69	11.32	36.25
Property, Plant & Equipment	3.17	3.49	2.83	3.68	1.12	1.03
Long-Term Investments	2.5	2.5	2.5	2.5	0.4	0.19
Long-Term Deferred Charges	-	-	-	4	0.1	-
Other Long-Term Assets	1.28	1.02	0.77	0.71	0.59	0.63
Total Assets	42.83	76.17	95.21	95.57	13.53	38.09
Accounts Payable	5.31	5.13	2.9	3.97	2.03	1.77
Accrued Expenses	6.65	6.08	5.15	5.38	1.89	1.41
Current Portion of Long-Term Debt	-	-	-	-	2	4
Current Portion of Leases	0.64	0.55	0.65	0.7	-	-
Current Unearned Revenue	4.46	4.44	2.51	6.44	5.54	5.8
Other Current Liabilities	-	-	-	2.09	0.78	1.38
Total Current Liabilities	17.06	16.21	11.21	18.57	12.24	14.36
Long-Term Debt	14.38	14.29	-	9.49	3.67	5.46
Long-Term Leases	1.33	1.69	1.04	1.68	-	-
Long-Term Unearned Revenue	9.57	10.99	14.92	13.1	16.86	15.12
Other Long-Term Liabilities	0.19	0.04	-	0.2	0.54	0.24
Total Liabilities	42.53	43.22	27.17	43.04	33.31	35.18
Common Stock	0	0	0	0	-	-
Additional Paid-In Capital	348.27	342.78	316.9	252.27	94.89	94.57
Retained Earnings	-348	-309.88	-248.85	-199.73	-166.13	-143.11
Comprehensive Income & Other	0.02	0.05	-0.01	-0.01	-	-0
Total Common Equity	0.3	32.96	68.04	52.53	-71.23	-48.54
Shareholders' Equity	0.3	32.96	68.04	52.53	-19.78	2.91
Total Liabilities & Equity	42.83	76.17	95.21	95.57	13.53	38.09
Total Debt	16.35	16.53	1.69	11.87	5.67	9.46
Net Cash (Debt)	17.57	50.28	85.91	71.92	5.22	26.33
Net Cash Growth	-72.43%	-41.47%	19.46%	1276.89%	-80.17%	-
Net Cash Per Share	0.46	1.37	2.59	4.80	2.47	13.08
Filing Date Shares Outstanding	53.96	38.31	35.78	2.52	2.19	2.01
Total Common Shares Outstanding	38.64	38.19	35.78	2.52	2.19	2.01
Working Capital	18.82	52.96	77.91	66.12	-0.92	21.89
Book Value Per Share	0.01	0.86	1.90	20.83	-32.60	-24.11
Tangible Book Value	0.3	32.96	68.04	52.53	-71.23	-48.54
Tangible Book Value Per Share	0.01	0.86	1.90	20.83	-32.60	-24.11
Machinery	2.67	2.53	2.12	2.08	1.51	1.24
Construction In Progress	-	-	-	-	0.02	0.04
Leasehold Improvements	0.16	0.16	0.2	0.19	0.18	0.17

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q